Today, we honor and remember Kimberly Smith — a pillar of the Cancer Warriors community and someone who meant everything to so many of us. With heavy hearts, we share that Kimberly has passed away. Her oldest son Troy and her husband Bob were kind enough to reach out, knowing how much this community meant to her. Troy shared: “This group was a big part of her journey and her fight. She lived to inspire others to do the hard things and take control of how they treated their cancer, to question standard of care and seek valid alternatives to chemotherapy. Thank you all for your support.” Just two months before her passing, on October 25th, Kimberly shared a post here that now reads as a powerful reflection of who she was: She wrote about living 22 months progression-free, with periods of NED, and about having outlived her original prognosis. She celebrated meaningful victories — her son returning safely from Iraq, time spent at the farm, and a life still being lived with intention. At the same time, she spoke with honesty about progression, fatigue, uncertainty, and difficult decisions — always thoughtful, informed, and grounded in patient autonomy. She closed that post the same way she lived her journey: “Love and healing to you all.” That was Kimberly. She was deeply loved, deeply respected, and profoundly impactful. She wasn’t just an admin — she was a leader, an advocate, and a steady voice of reason and courage for countless people navigating cancer. She contributed immensely through sharing her journey, her research, and her unwavering commitment to patient awareness. Kimberly believed in empowerment. She believed in asking hard questions. She believed in doing the hard thing — even when it meant standing apart from conventional paths. Through her posts, her constant support of others, her leadership, and her role as host of the Cancer Warriors Podcast, Kimberly helped educate and inspire so many. Those conversations, shared publicly on YouTube, remain part of her living legacy.

Hi warriors! 👋 I have disease progression for the first time since initial diagnosis in June 2023. During the past 5 months I stopped HBOT and drugs from the ReDO protocol. I feel strongly vindicated by this result (albeit a setback) and affirmed that my research, inferences, learnings and previous strategies had me on the right track. This is because I now have strong evidence that the repurposed drugs I selected (based on drug sensitivity testing and oncogene analysis) in conjunction with a fatty meat-based ketogenic diet, HBOT, nutraceuticals etc. works. I think people also need to be warned that there’s lots of “natural healing” crap on social media that isn’t genuine in the context of cancer care - the natural elements are often overstated and used as clickbait and the influencers hide the fact they actually also used SOC (chemo, radiation, immunotherapy and/or surgery) to resolve cancer. It’s only after reaching NED status that they start promoting adjuncts as if they are a stand-alone solution and this is dangerous and deceptive. Yes, I declined SOC and still don’t want radiation, colostomy surgery or intravenous chemotherapy. But everything I have done is backed by scientific literature - I’m not blessing celery juice under a full moon and singing kumbyaya! Clearly, my attempt at “healing” did not work! Stopping the strategies in my previous protocol and eliminating pharmaceuticals did NOT heal my gut. Eating more vegetables for polyphenols and eating less animal protein did not work for me (and I don’t care about all the pro-fibre propaganda - it’s nonsensical to promote eating copious amounts of indigestible plant matter when you have an inflamed colon, compromised permeability, dysbiosis and an ulcerative bleeding tumour!). Just like that after over two and a half years of stability (no growth) and/or results of gradual tumour size reduction, getting closer and closer to NED status … and BOOM: the tumour doubled in size when I followed more “mainstream” medical advice! 💥 The recent PET scan indicates there is 4cm of high avidity in the tumour microenvironment (confirmed by MRI measurements of 20x17x36) so shrimpy boy (my name for the tumour as it literally looks like a mangled bleeding prawn) is certainly still gobbling up glucose! 🤣🍤

I’ve not been well for the past 4 days. I did have diarrhoea and fatigue last week and it’s continued this week as well. I might have picked up a bug form a school carol service or the Iscador Qu is really reacting with me. I do have very inflamed and tender injection sites.

I’d like to share a story from my new hero, who sent me an email today. He’s my new hero because he indirectly helped me stabilize my prostate MRI scan and improve my prostate symptoms, thus renewing my hope. I hope this story can be a source of inspiration for you all. Happy reading *The Electric Language of Life* (An essay in four movements) What cells know that our textbooks still refuse to say. Dr. h.c. Andreas Ludwig Kalcker November 29, 2025 In 2012, a senior oncologist in Madrid (I will call him Miguel) diagnosed his closest friend since university, Luis, with locally advanced pancreatic adenocarcinoma. The tumor had already wrapped itself around the superior mesenteric vessels. No surgical option. The guidelines were clear: palliative chemotherapy might buy a few extra weeks of nausea and fatigue, nothing more. Miguel sat Luis down in his office after hours, closed the door, and did something most oncologists never allow themselves to do. He spoke the truth. “Luis, the statistics are brutal. Even with treatment you have three to six months, probably less. Chemo will make you feel like death while only postponing it by days. If it were me, I would skip it.” Luis listened, pale but strangely calm. He asked only one question: “So I can do what I want with the time I have left?” Miguel nodded. Two weeks later Luis flew to Bali with a one-way ticket, leaving behind a stunned family; he refused to participate. He had always wanted to see the coral reefs before he died. He rented a small losmen on the coast near Amed,, and started diving every single day—sometimes three or four dives. The salt water, the weightlessness, the pure oxygen-enriched air from the tanks, the sun on his skin. He started to feel alive in a way he had never felt in his job translating contracts in a grey Madrid office. One of the divemasters noticed how quickly Luis moved through the water and asked where he had learned. They offered him a job teaching German tourists. He accepted. He never went back.

Hey Warriors 🙂, I’ve been a bit quieter lately as we’ve been working behind the scenes on something important: My mum completed the Astron Health multi-omic analysis, and the results have finally arrived. Next week we meet Astron’s integrative oncologist to go through the full interpretation — but I want to share the key insights now, because this is something that can empower every person in this community. ⭐ What Astron Revealed About My Mum’s Cancer Her tumour is not random. It runs on specific biological pathways — almost like an engine with identifiable components. The major drivers they identified were: 🔥 FGFR2 → MAPK (Main Growth Engine) 🔥 VEGF / Angiogenesis (Blood Supply) 🔥 MMP15 (Invasion + Tissue Breakdown) 🔥 WNT Signalling (Stem-Cell Survival + Recurrence) 🔥 FANCA Mutation (DNA-Repair Weakness → ROS Sensitivity) And important update: ➡️ CTCs were only 2, which is very low and extremely reassuring. ⭐ This Report Was NOT Essential — But It Was Incredibly Helpful I want to make something clear to everyone: You do NOT need expensive molecular testing to build an effective, multi-pathway protocol. Over the past 1.5 years, I created my mum’s protocol by studying: - cancer signalling pathways - metabolic vulnerabilities - invasion markers - angiogenesis mechanisms - mitochondrial weaknesses - stem-cell biology And what shocked me was this: The Astron findings matched almost exactly what I had already built through research alone. This is HUGE for this community. It proves that: ✔ you can learn what drives your cancer ✔ you can build precision strategies without testing ✔ you can target the actual pathways behind the disease ✔ you do NOT need to shoot in the dark The report confirmed the work — it didn’t create it. ⭐ The One Pathway We Had Not Fully Targeted: RAS → MAPK Astron’s report highlighted one important component: Atorvastatin This inhibits RAS prenylation, which is the top upstream switch that activates the MAPK pathway — the main engine of her tumour.